Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: Insight into the functional role of mutant fibrillin-1
- 15 May 2006
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 312 (9), 1463-1474
- https://doi.org/10.1016/j.yexcr.2006.01.011
Abstract
The tight skin (Tsk/+) mouse is a model for fibrotic disorders. The genetic defect in the Tsk/+ is an in-frame duplication between exons 17 and 40 of the fibrillin-1 gene which gives rise to a large transcript and protein. Mice homozygous for the mutation die in utero, whereas heterozygotes survive and spontaneously develop connective tissue disease. In this study, we generated hammerhead ribozymes directed against the mutant fibrillin-1 transcript. A partially mispairing ribozyme was the most effective vehicle to cleave the mutant transcript without undesired cleavage of wild type transcripts, as shown by cell-free RNA cleavage and cleavage in cell lines harboring the ribozyme, by RT-PCR, Northern and Western Blotting. Global gene expression profiling using oligonucleotide microarrays showed the expected reduction in fibrillin-1 mRNA, and down-regulation of several gene cohorts in ribozyme harboring TskR1 cells compared to Tsk/+ cells. Two of the functional clusters included genes regulating extracellular matrix such as connective tissue growth factor, serpine-1 (plasminogen activator inhibitor-1) and TIMP-1 and TIMP-3, and those involved in cytoskeletal organization and myofibroblast formation including calponins and transgelin. Ribozyme-mediated inhibition was confirmed by Western Blot and functional analysis using cell-reporter systems and remodeling of three dimensional collagen gels. Our results underline the therapeutic potential of hammerhead ribozymes in dominant negative defects and suggest that changes in microfibril architecture brought about by fibrillin-1 mutation lead to a complex disease phenotype.Keywords
Funding Information
- Sir Jules Thorn Charitable Trust
- Raynaud’s and Scleroderma Association
This publication has 59 references indexed in Scilit:
- Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF)Cellular Signalling, 2006
- Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agentsLaboratory Investigation, 2005
- Fibrillin microfibrils: multipurpose extracellular networks in organismal physiologyPhysiological Genomics, 2004
- Fine tuning of growth factor signals depends on fibrillin microfibril networksBirth Defects Research Part C: Embryo Today: Reviews, 2004
- Fibrillin 1 abnormalities in dermal fibroblast cultures from first‐degree relatives of patients with systemic sclerosis (scleroderma)Arthritis & Rheumatism, 2004
- Transforming growth factor-β1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation systemExperimental Cell Research, 2003
- Activation of a fibroblast-specific enhancer of the Pro?2(I) collagen gene in tight-skin miceArthritis & Rheumatism, 2001
- Interaction of Tropoelastin with the Amino-terminal Domains of Fibrillin-1 and Fibrillin-2 Suggests a Role for the Fibrillins in Elastic Fiber AssemblyPublished by Elsevier BV ,2000
- Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblastsHuman Molecular Genetics, 1996
- Congenital fascial dystrophy: Stiff skin syndrome—a human counterpart of the tight-skin mouseJournal of the American Academy of Dermatology, 1989